Beranda0460 • HKG
add
Sihuan Pharmaceutical Holdings Group Ltd
Tutup sebelumnya
$0,72
Rentang hari
$0,70 - $0,73
Rentang tahun
$0,50 - $1,02
Kapitalisasi pasar
6,55 M HKD
Volume Rata-Rata
38,20 jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
HKG
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CNY) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 475,71 jt | 18,21% |
Biaya operasional | 513,62 jt | 37,16% |
Laba bersih | -91,62 jt | -4.090,21% |
Margin laba bersih | -19,26 | -3.466,67% |
Penghasilan per saham | — | — |
EBITDA | -151,84 jt | -135,94% |
Tarif pajak efektif | 1,34% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,63 M | -16,82% |
Total aset | 10,53 M | -8,70% |
Total liabilitas | 5,58 M | -12,76% |
Total ekuitas | 4,95 M | — |
Saham yang beredar | 9,24 M | — |
Harga terhadap nilai buku | 1,53 | — |
Tingkat pengembalian aset | -4,68% | — |
Tingkat pengembalian modal | -8,36% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -91,62 jt | -4.090,21% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province. The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market.
Sihuan Pharmaceutical is collaborating with the Academy of Military Medical Science in the development of the drug JK-05, intended for the treatment of Ebola virus disease. The company has been challenged by Fujifilm Holdings Corporation, which has stated that JK-05 infringes its patent rights regarding Avigan. Wikipedia
CEO
Didirikan
2001
Situs
Karyawan
2.667
